86.81 0.00 (0.00%)
After hours: 4:43PM EDT
|Bid||85.25 x 1300|
|Ask||88.35 x 4000|
|Day's Range||86.61 - 87.58|
|52 Week Range||76.41 - 89.72|
|PE Ratio (TTM)||38.24|
|Earnings Date||Aug 21, 2018|
|Forward Dividend & Yield||1.84 (2.12%)|
|1y Target Est||94.55|
Let's check out the Yahoo Finance charts of the day. United Rentals (URI): Shares are up in early trade, at around 3.6%. UBS upgraded the equipment rental company to "buy" from "neutral". UBS said cyclical and cost concerns surrounding the company are overdone. Blackberry (BB): Shares down here, at 6.9%. The software and services company saw revenue top estimates. Blackberry reported adjusted first-quarter profit of 3 cents per share, compared to analysts' expectations of a breakeven quarter. Medtronic (MDT): Shares are up slightly here, at around .82%. The medical device company said Friday its board has approved a 9% increase in its quarterly cash dividend to 50 cents a share. For more on today's big stock movers check out the Final Round, live at 3:55 p.m. ET, right here on Yahoo Finance.
June 22, 2018 - Medtronic plc (MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM) Watson Health, today announced commercial availability of the Sugar.IQ(TM) smart diabetes assistant, a first-of-its-kind intelligent app designed to simplify and improve daily diabetes management. Approximately 30.3 million Americans have been diagnosed with diabetes, with 1.5 million new cases being diagnosed every year.1 More than 6 million of those impacted use insulin to manage their diabetes.2 People with diabetes face many daily challenges - managing their condition, understanding medical advice, knowing what to eat and when, the impact of food and activity on sugar levels, and trying to avoid critical glycemic events.
The medical device maker announced Thursday the FDA approved its t:slim X2 Insulin pump with Basal-IQ technology. Tandem Diabetes expects to make the t:slim X2 pump with Basal-IQ technology available in the U.S. in August.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 21) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) FibroGen Inc (NASDAQ: ...
BlackBerry BB-CA – BlackBerry reported adjusted first-quarter profit of 3 cents per share, compared to analysts' expectations of a breakeven quarter. JPMorgan Chase JPM , Bank of America BAC , Citigroup C , Wells Fargo WFC – These and other bank stocks are on watch today after 35 of the nation's largest banks passed the Fed's latest stress tests. The software provider's revenue also beat forecasts on strong demand from large companies, but its current-quarter and full-year revenue forecasts are short of analysts' estimates due to a strengthening dollar.
MARKET PULSE Medtronic Plc (mdt) said Friday its board has approved a 9% increase in its quarterly cash dividend to 50 cents a share. The new dividend payment will be made on July 25 to shareholders of record as of July 6.
June 22, 2018 - The board of directors of Medtronic plc (MDT) today approved a 9 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.50 per ordinary share. This would translate into an annual amount of $2.00 per ordinary share, or a dividend per share payout ratio of 42 percent of prior fiscal year non-GAAP diluted earnings per share (EPS). Today`s announcement marks the 41st consecutive year of an increase in the dividend payment for Medtronic, a constituent of the S&P 500 Dividend Aristocrats index.
May marked the 92nd straight month in which U.S. employers added workers to their collective ranks. However, Minnesota's biggest public companies aren't all adding employees.
DUBLIN- June 21, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of the MiniMed(TM) 670G system in patients with type 1 diabetes seven years of age and older. This newest system by Medtronic features the company`s most advanced SmartGuard(TM) technology and most accurate CGM - the Guardian Sensor 3 - which work together to automate the delivery of a personalized amount of basal insulin every five minutes based on sensor glucose values. "The MiniMed 670G system is the most advanced insulin delivery system on the market today and proven to effectively manage type 1 diabetes," said Dr. Jennifer Sherr, a pediatric endocrinologist at Yale New Haven Children`s Hospital`s diabetes clinic and an associate professor of pediatric endocrinology at the Yale School of Medicine.